This refers to tumors or growths in the iris. These growths are often caused by an overgrowth of pigment cells called melanocytes. Some iris growths are harmless (like iris nevi), while others can be cancerous.
Every report comes from a Lived member, sent anonymously.
Have you had Brachytherapy for Iris Tumors?
Iris tumors are growths in the iris, the colored ring at the front of the eye that surrounds the pupil. The term covers a wide range of lesions, and most of them are not cancer. In large specialist series, the most common are an iris nevus (a flat or slightly raised freckle-like collection of pigment cells), a cyst (a small fluid-filled pocket, usually on the back surface of the iris) and, less often, iris melanoma. Iris melanoma is a cancer of the pigment-making cells of the iris. It belongs to the same family as melanoma in the deeper layers of the eye (uveal melanoma), but it is usually smaller, grows more slowly and spreads to other parts of the body far less often. A tumor in the iris can also be cancer that has spread there from somewhere else, most often the breast or lung, and occasionally this is the first sign of that cancer. Because these possibilities lead to very different plans, the main question with any iris growth is which kind it is. Many iris tumors cause no symptoms and are noticed during a routine eye exam or as a spot in the colored part of the eye. Some change the shape of the pupil, darken part of the iris, or raise the pressure inside the eye.
For most iris tumors there is no known trigger. Iris nevi and melanomas are more common in people with light-colored eyes and fair skin, and melanoma risk rises with age, although iris melanoma can occur at any age, including in children. A small share of iris nevi grow into melanoma over many years, which is why a nevus is usually watched rather than ignored. Whether sunlight plays a role is not settled. Genetic studies have found a pattern of ultraviolet damage in some iris melanomas that is not seen in melanomas deeper in the eye, but studies of people's actual sun exposure have not shown a consistent link. Some iris growths point to a condition elsewhere in the body. Lisch nodules, small tan bumps on the iris, are a characteristic sign of neurofibromatosis type 1 (NF1), an inherited condition that also affects the skin and nerves, and they are one of the findings used to diagnose it. An iris metastasis arises because a cancer elsewhere has spread through the bloodstream.
An eye doctor examines the iris with a slit lamp, a microscope with a bright beam of light, and usually checks the eye pressure and looks into the drainage angle where the iris meets the clear front of the eye (gonioscopy). Features such as the size, color, blood vessels, edges and effect on the pupil help separate a nevus or cyst from something more concerning. Photographs taken at the first visit are an important part of the assessment, because growth over time is the most reliable clinical sign that a pigmented lesion may be melanoma. Ultrasound biomicroscopy, a high-frequency ultrasound of the front of the eye, measures the tumor's thickness, shows whether it is solid or a cyst, and checks whether it reaches the ciliary body, the tissue just behind the iris. Optical coherence tomography, a light-based scan, can help with small surface lesions. A biopsy is rarely needed. When the diagnosis remains uncertain, or cancer spread from elsewhere is suspected, a specialist may take a small sample with a fine needle or test fluid from the front of the eye. If a metastasis is likely, the workup also looks for the original cancer.
Treatment depends on what the tumor is. Most nevi need no treatment beyond monitoring, and cysts usually stay stable and rarely need treatment. For iris melanoma, care is usually led by an eye cancer specialist (ocular oncologist). Because the tumor is rare, advice is based on case series rather than large trials. A small melanoma that is not growing and causing no problems may be watched with regular photographs. When growth is documented, surgery to remove the tumor along with a section of the iris (iridectomy, extended into the ciliary body if needed) can treat it while keeping the eye. Plaque radiation therapy, in which a small radioactive disc is stitched temporarily onto the eye over the tumor, is used for tumors too large or widespread to cut out. Removing the eye (enucleation) is reserved for melanoma that involves much of the iris or drainage angle, causes glaucoma that cannot be controlled, or has grown outside the eye; an artificial eye is fitted afterward. In a large series, the choice among surgery, radiation and eye removal did not change the chance of the cancer spreading, so the decision mostly balances tumor control against the effects on the eye. Each treatment has trade-offs. Surgery removes part of the iris, so it permanently changes the shape of the pupil. After plaque radiation, cataract and raised eye pressure are common, and some people later need cataract surgery or glaucoma treatment. Cancer that has spread to the iris is treated mainly as part of the original cancer, with medicines that work throughout the body, sometimes combined with radiation to the eye, in coordination with the person's oncologist.
Most people with an iris nevus or cyst keep normal vision and simply have periodic eye exams. A suspicious lesion is often checked every few months at first, then about once a year if it stays the same. Over long follow-up, a small minority of nevi grow into melanoma; in one large referral-center series this happened in about 8 percent of eyes by 15 years, more often in younger people, nevi in the lower half of the iris, and lesions that had bled or had feathery edges. Iris melanoma generally has a good outlook. Five-year survival is above 95 percent, and in one long-term series the cancer had spread elsewhere in about 3 percent of people at 5 years and about 10 percent at 20 years. Tumors at the outer edge of the iris, those with high eye pressure, and those growing outside the eye carry more risk. Because spread can occur late, follow-up continues for many years, often with a glaucoma specialist as well if eye pressure becomes a problem after treatment. For a metastasis to the iris, vision is often preserved with treatment, but the overall outlook depends on the original cancer and how far it has spread.
Arrange an eye exam if you notice a new dark or light spot on the iris, a spot that seems to be growing or changing color, a change in the shape or size of the pupil, or one eye's color becoming darker than the other. If you have a known iris lesion, keep scheduled follow-up visits so photographs can be compared. Seek same-day eye care for new eye pain, blurred vision, unusual glare or light sensitivity, or visible blood in the front of the eye, since an iris tumor can raise eye pressure or bleed.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Iris Tumors is like, what's helped you, or ask the community a question.